USPTO serial 79389188
ACELLYTRON THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 30, 2025
- Examiner
- THOMAS, JULIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ACELLYTRON THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch Stewart Kolasch & Birch, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemico-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressor; cells for medical use; dietetic infusions, sugar, foods, and beverages adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, and for the treatment of cancer | ACTIVE | — |
| 035 | Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies | ACTIVE | — |
| 042 | Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects | ACTIVE | — |
| 044 | Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wuxi Biologics (Shanghai) Co., Ltd.
- Other trademarks owned by Wuxi Biologics (Shanghai) Co., Ltd.
- Other trademarks owned by Wuxi Biologics (Shanghai) Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACELLYTRON THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 6, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 6, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 15, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 15, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 7, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jun 27, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 12, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |